Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis

Clinical trial NCT07439536 · COMPLETED

Trial details

NCT number: NCT07439536
Sponsor: Kafrelsheikh University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Liver Cirrhosis With Diabetes

Start date: 2024-07-01
Primary completion: 2025-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.